Cor Vasa 2019, 61(6):584-587 | DOI: 10.33678/cor.2019.051
(Application of 0/1-h high sensitivity cardiac troponin algorithm in the cardiology outpatient department)
- a Kardiologické oddělení, Pardubická nemocnice, Pardubice
- b Oddělení klinické biochemie a diagnostiky, Pardubická nemocnice, Pardubice
Background: Chest pain is one of the commonest reasons for emergency department visits. Acute myocardial infarction is diagnosed in minority of these patients. Diagnostic algorithms based on high-sensitivity troponin assays enable fast and safe AMI diagnostics. The aim of the present study is to explore effectivity of one-hour (0/1-h) high sensitivity troponin algorithm in management of patients with chest pain in outpatients department of Cardiology department and to describe subgroups of patients.
Methods: Patients with chest pain presenting to outpatients department of Cardiology department of Pardubice District Hospital were prospectively examined with 0/1-h high sensitivity troponin I (ADVIA Centaur TNIH, Siemens Healthineers, Erlangen, Germany). According to troponin I concentration and its dynamics, they were divided with use of validated algorithm into rule-out, observe and rule-in. Patients with STEMI and on hemodialysis were excluded. We compare subgroups of patients in their basic characteristics.
Results: From 1st May to 31st June 2018 135 patients were prospectively included. Based on hsTnI and 0/1-h algorithm they were divided into three subgroups - rule-out, observe and rule-in. 64 (47.4%) patients were classified to rule-out, 59 (43.7%) to observe and 12 patients (8.9%) to rule-in subgroup. Non-STEMI was diagnosed in 8 patients (5.9%) and all of these were classified as rule-in. Negative and positive predictive value was 100% and 75%, respectively. The observed subgroup had significantly more risk factors than rule-out patients.
Conclusion: Management of chest pain patients with 0/1-h algorithm is effective in the outpatients department. It enables fast and safe rule-out of AMI in one half of patients. Observed subgroup patients have more risk factors and should be further investigated.
Keywords: Algorithm, High sensitivity troponin, Myocardial infarction, Troponin
Received: April 8, 2019; Accepted: June 15, 2019; Published: December 15, 2019 Show citation
References
- Mockel M, Searle J, Muller R, et al. Chief complaints in medical emergencies: do they relate to underlying disease and outcome? The Charite Emergency Medicine Study (CHARITEM). Eur J Emerg Med 2013;20:103-108.
Go to original source...
Go to PubMed...
- Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation 2014;130:2354-2394.
Go to original source...
Go to PubMed...
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2018;40:237-269.
Go to original source...
Go to PubMed...
- Twerenbold R, Boeddinghaus J, Nestelberger T, et al. Clinical use of high-sensitivity troponin in patients with suspected myocardial infarction. J Am Coll Cardiol 2017;70:996-1012.
Go to original source...
Go to PubMed...
- Pickering JW, Greenslade JH, Cullen L, et al. Assesment of the European Society of Cardiology 0-Hour/1-Hour Algorithm to Rule-Out and Rule-In Acute Myocardial Infarction. Circulation 2016;134:1532-1541.
Go to original source...
Go to PubMed...
- Hollander JE, Than M, Mueller C. State-of-the-Art Evaluation of Emergency Department Patients Presenting With Potential Acute Coronary Syndromes. Circulation 2016;134:547-564.
Go to original source...
Go to PubMed...
- Twerenbold R, Neumann JT, Sörensen NA, et al. Prospective Validation of the 0/1-h Algorithm for Early Diagnosis of Myocardial Infarction. J Am Coll Cardiol 2018;72:620-632.
Go to original source...
Go to PubMed...
- Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
Go to original source...
Go to PubMed...
- Boeddinghaus J, Twerenbold R, Nestelberger T, et al. Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. Clin Chem 2018;64:1347-1360.
Go to original source...
Go to PubMed...
- Reichlin T, Hochholzer W, Bassetti S, et al. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. N Engl J Med 2009;361:858-867.
Go to original source...
Go to PubMed...
- Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012;172:1211-1218.
Go to original source...
Go to PubMed...
- Body R, Mueller C, Giannitsis E, et al. The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using Single Blood Test. Acad Emerg Med 2016;23:1004-1013.
Go to original source...
Go to PubMed...
- Chew DP, Zeitz C, Worthley M, et al. Randomized Comparison of High-Sensitivity Troponin Reporting in Undifferentiated Chest Pain Assesment. Circ Cardiovasc Qual Outcomes 2016;9:542-553.
Go to original source...
Go to PubMed...
- Nestelberger T, Wildi K, Boeddinghaus J, et al. Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h/1h-algorithm for the early diagnosis of acute myocardial infrction. Int J Cardiol 2016;207:238-245.
Go to original source...
Go to PubMed...
- Corsini A, Vagnarelli F, Bugani G, et al. Impact of high sensitivity Troponin T on hospital admission, resources utilization and outcomes. Eur Heart J Acute Cardiovasc Care 2015;4:148-157.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.